Miller PD - Search Results

1

Proceedings of the 2017 Santa Fe Bone Symposium: Insights and Emerging Concepts in the Management of Osteoporosis.

Lewiecki EM, Bilezikian JP, Carey JJ, Dell RM, Gordon CM, Harris ST, McClung MR, Miller PD, Rosenblatt M. Lewiecki EM, et al. Among authors: miller pd. J Clin Densitom. 2018 Jan-Mar;21(1):3-21. doi: 10.1016/j.jocd.2017.10.041. Epub 2017 Nov 20. J Clin Densitom. 2018. PMID: 29229501

2

Osteoporosis awareness in 1994.

Miller PD. Miller PD. Colo Med. 1994 Nov;91(11):398. Colo Med. 1994. PMID: 8001331 No abstract available.

3

Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy.

Harris ST, Watts NB, Jackson RD, Genant HK, Wasnich RD, Ross P, Miller PD, Licata AA, Chesnut CH 3rd. Harris ST, et al. Among authors: miller pd. Am J Med. 1993 Dec;95(6):557-67. doi: 10.1016/0002-9343(93)90350-x. Am J Med. 1993. PMID: 8259772 Clinical Trial.

4

Clinical utility of bone mass measurements in adults: consensus of an international panel. The Society for Clinical Densitometry.

Miller PD, Bonnick SL, Rosen CJ, Altman RD, Avioli LV, Dequeker J, Felsenberg D, Genant HK, Gennari C, Harper KD, Hodsman AB, Kleerekoper M, Mautalen CA, McClung MR, Meunier PJ, Nelson DA, Peel NF, Raisz LG, Recker RR, Utian WH, Wasnich RD, Watts NB. Miller PD, et al. Semin Arthritis Rheum. 1996 Jun;25(6):361-72. doi: 10.1016/s0049-0172(96)80001-1. Semin Arthritis Rheum. 1996. PMID: 8792508 Review.

5

Use of bone densitometry results for decisions about therapy for osteoporosis.

Ettnger B, Miller P, McClung MR. Ettnger B, et al. Ann Intern Med. 1996 Oct 1;125(7):623. doi: 10.7326/0003-4819-125-7-199610010-00021. Ann Intern Med. 1996. PMID: 8815769 No abstract available.

6

Prediction of fracture risk. I: Bone density.

Miller PD, McClung M. Miller PD, et al. Am J Med Sci. 1996 Dec;312(6):257-9. doi: 10.1097/00000441-199612000-00003. Am J Med Sci. 1996. PMID: 8969614 Review.

7

Cyclical etidronate in the treatment of postmenopausal osteoporosis: efficacy and safety after seven years of treatment.

Miller PD, Watts NB, Licata AA, Harris ST, Genant HK, Wasnich RD, Ross PD, Jackson RD, Hoseyni MS, Schoenfeld SL, Valent DJ, Chesnut CH 3rd. Miller PD, et al. Am J Med. 1997 Dec;103(6):468-76. doi: 10.1016/s0002-9343(97)00278-7. Am J Med. 1997. PMID: 9428829 Clinical Trial.

8

Risedronate in the treatment of Paget's disease of bone: an open label, multicenter study.

Siris ES, Chines AA, Altman RD, Brown JP, Johnston CC Jr, Lang R, McClung MR, Mallette LE, Miller PD, Ryan WG, Singer FR, Tucci JR, Eusebio RA, Bekker PJ. Siris ES, et al. Among authors: miller pd. J Bone Miner Res. 1998 Jun;13(6):1032-8. doi: 10.1359/jbmr.1998.13.6.1032. J Bone Miner Res. 1998. PMID: 9626635 Free article. Clinical Trial.

9

Management of postmenopausal osteoporosis for primary care.

Miller P, Lukert B, Broy S, Civitelli R, Fleischmann R, Gagel R, Khosla S, Lucas M, Maricic M, Pacifici R, Recker R, Sarran HS, Short B, Short MJ. Miller P, et al. Menopause. 1998 Summer;5(2):123-31. Menopause. 1998. PMID: 9689207 Review.

10

Management of osteoporosis.

Miller PD. Miller PD. Adv Intern Med. 1999;44:175-207. Adv Intern Med. 1999. PMID: 9929709 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

443 results

Search Page